| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.17 | 0.3 |